As President-elect Donald Trump was getting ready for Inauguration Day in New York, across the ocean, Pfizer CEO Ian Read was dispelling Trump’s remarks that pharma firms are “getting away with murder.” “Most of the problem of reputation is coming from those that I don’t consider part of the ethical pharmaceutical business,” Read said during…
2016 Trends Survey: Most Biopharma Professionals Hopeful for Future
The majority of biopharma professionals are highly optimistic for the future growth of the biopharma sector, 69 percent, according to a recent survey composed by the National Institute of Bioprocessing Research and Training. NIBRT based its findings on 101 respondents to whom the survey was sent mid-December of 2016. “There is a strong consensus that monoclonal…